---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-057679"
form_type: "8-K"
ticker: "A"
cik: "0001090872"
company_name: "AGILENT TECHNOLOGIES, INC."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:25:49.602986+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Agilent expands board to 12, appoints Dr. Otis Brawley, oncology expert

## Summary
- Board expanded from 11 to 12 with appointment of Dr. Otis W. Brawley, effective Nov. 17, 2021.
- Brawley will serve on Compensation and Nominating/Corporate Governance Committees.
- He is Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University.
- Also serves on boards of Incyte Corp., Lyell Immunopharma, and PDS Biotechnology.
- Receives standard non-employee director compensation, pro-rated for remainder of 2021.

## SEC filing metadata
- accession: 0001564590-21-057679
- form_type: 8-K
- ticker: A
- cik: 0001090872
- company_name: AGILENT TECHNOLOGIES, INC.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1090872/000156459021057679/0001564590-21-057679-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1090872/000156459021057679/a-8k_20211117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-057679
- JSON: https://secwatch.observer/filing/0001564590-21-057679.json
- Plain text: https://secwatch.observer/filing/0001564590-21-057679.txt

## Key facts
- Executive change
  Otis W. Brawley was appointed as Director at AGILENT TECHNOLOGIES, INC..
  - Action: appointed
  - Role: Director
  source text: increased the size of the Board from 11 to 12 members and appointed Otis W. Brawley, M.D., to fill the vacancy so created, both effective November 17, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1090872/000156459021057679/0001564590-21-057679-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.